Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers
Clinical trial NCT05162131 · TERMINATED
Trial details
- NCT number
- NCT05162131
- Sponsor
- SFJ Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-25
- Primary completion
- 2022-12-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.